Patients With Monogenic Or Polygenic FH Have Elevated Risk For ASCVD Compared With Patients With Nongenetic Hypercholesterolemia, Study Indicates
March 13, 2020
Cardiology Advisor (3/12, Rothbard) reports that in a study, patients “with monogenic or polygenic familial hypercholesterolemia (FH) were found to be at an elevated risk for atherosclerotic cardiovascular disease (ASCVD) compared with those with nongenet...